Riley JL - Search Results

1

Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand.

Bauer DE, Harris MH, Plas DR, Lum JJ, Hammerman PS, Rathmell JC, Riley JL, Thompson CB. Bauer DE, et al. Among authors: riley jl. FASEB J. 2004 Aug;18(11):1303-5. doi: 10.1096/fj.03-1001fje. Epub 2004 Jun 4. FASEB J. 2004. PMID: 15180958 Free PMC article.

2

The CD28 signaling pathway regulates glucose metabolism.

Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC, Plas DR, Elstrom RL, June CH, Thompson CB. Frauwirth KA, et al. Among authors: riley jl. Immunity. 2002 Jun;16(6):769-77. doi: 10.1016/s1074-7613(02)00323-0. Immunity. 2002. PMID: 12121659 Free article.

3

CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.

Parry RV, Chemnitz JM, Frauwirth KA, Lanfranco AR, Braunstein I, Kobayashi SV, Linsley PS, Thompson CB, Riley JL. Parry RV, et al. Among authors: riley jl. Mol Cell Biol. 2005 Nov;25(21):9543-53. doi: 10.1128/MCB.25.21.9543-9553.2005. Mol Cell Biol. 2005. PMID: 16227604 Free PMC article.

4

Modulation of susceptibility to HIV-1 infection by the cytotoxic T lymphocyte antigen 4 costimulatory molecule.

Riley JL, Schlienger K, Blair PJ, Carreno B, Craighead N, Kim D, Carroll RG, June CH. Riley JL, et al. J Exp Med. 2000 Jun 5;191(11):1987-97. doi: 10.1084/jem.191.11.1987. J Exp Med. 2000. PMID: 10839813 Free PMC article.

5

ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement.

Riley JL, Blair PJ, Musser JT, Abe R, Tezuka K, Tsuji T, June CH. Riley JL, et al. J Immunol. 2001 Apr 15;166(8):4943-8. doi: 10.4049/jimmunol.166.8.4943. J Immunol. 2001. PMID: 11290772

6

Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation.

Woo EY, Yeh H, Chu CS, Schlienger K, Carroll RG, Riley JL, Kaiser LR, June CH. Woo EY, et al. Among authors: riley jl. J Immunol. 2002 May 1;168(9):4272-6. doi: 10.4049/jimmunol.168.9.4272. J Immunol. 2002. PMID: 11970966

7

A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes.

Thomas AK, Maus MV, Shalaby WS, June CH, Riley JL. Thomas AK, et al. Among authors: riley jl. Clin Immunol. 2002 Dec;105(3):259-72. doi: 10.1006/clim.2002.5277. Clin Immunol. 2002. PMID: 12498807

8

HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells.

Maus MV, Riley JL, Kwok WW, Nepom GT, June CH. Maus MV, et al. Among authors: riley jl. Clin Immunol. 2003 Jan;106(1):16-22. doi: 10.1016/s1521-6616(02)00017-7. Clin Immunol. 2003. PMID: 12584046

9

TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.

Schlienger K, Chu CS, Woo EY, Rivers PM, Toll AJ, Hudson B, Maus MV, Riley JL, Choi Y, Coukos G, Kaiser LR, Rubin SC, Levine BL, Carroll RG, June CH. Schlienger K, et al. Among authors: riley jl. Clin Cancer Res. 2003 Apr;9(4):1517-27. Clin Cancer Res. 2003. PMID: 12684428

10

CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes.

Parry RV, Rumbley CA, Vandenberghe LH, June CH, Riley JL. Parry RV, et al. Among authors: riley jl. J Immunol. 2003 Jul 1;171(1):166-74. doi: 10.4049/jimmunol.171.1.166. J Immunol. 2003. PMID: 12816995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

374 results

Search Page

Filters